News
Researchers conducted the REDEFINE 1 and REDEFINE 2 clinical trials to assess the effect of CagriSema on weight loss in obesity with or without type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback